Dopamine-induced coronary effects in the dog heart attributed to β- and α-adrenergic mechanisms

G. Rabloczky, V. Kekesi, M. R. Mader, A. Juhasz-Nagy

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Open chest anesthetized dogs were given dopamine (DA) in intravenous (i.v. 2-16 μg·kg-1·min-1) and intracoronary (i.c., 10-40 μg·min-1) infusions. The drug effect was analyzed using the nonselective β-adrenoceptor antagonist oxprenolol (0.5 mg·kg, i.v.) and the nonselective α-adrenoceptor antagonsit phentolamine (1.0 mg·,g-1, i.v.). Coronary blood flow (CBF, electromagnetic flowmeter), arterial pressure and left ventricular contractile force (strain gauge) were measured. Coronary vascular responses were characterized by changes of CBF and calculated coronary vascular resistance (CVR). In the control state, DA-induced arterial hypertension (i.v. administration) and augmented inotropism (i.v. and i.c. administration) were accompanied by a dose-dependent coronary vasodilatation (increase of CBF and decrease of CVR). Oxprenolol converted coronary vasodilatation to vasoconstriction during DA infusions and blocked the inotropic action; the hypertensive DA effect remained unaffected. Similar alterations were observed after a transitory (45 min) regional myocardial ischemia, elicited by coronary occlusion. On the other hand, phentolamine-pretreatment potentiated the DA-induced coronary vasodilatation and converted hypertension to hypotension; the inotropic component of the DA action was not affected. After combined β- and α-blockade, DA failed to increased CBF and decrease CVR during the infusion periods. Instead, the drug elicited a very slight coronary vasoconstriction. I.c. (but not i.v.) infusions of DA were regularly followed by a rebound-like, transient CBF increase, even after combined β- and α-blockade. These results show that all of the multifactorial determinants of the direct steady state coronary effects of DA can be ascribed to α- and β-adrenoceptor stimulation, whereas the hypothetical dopaminergic coronary vascular receptors do not seem to play a decisive role in these responses. However, undefined after-effects provoked by i.c. DA, may be connected with specific dopaminergic effects.

Original languageEnglish
Pages (from-to)109-126
Number of pages18
JournalArchives internationales de pharmacodynamie et de therapie
Volume293
Issue number1
Publication statusPublished - Jan 1 1988

ASJC Scopus subject areas

  • Pharmacology

Fingerprint Dive into the research topics of 'Dopamine-induced coronary effects in the dog heart attributed to β- and α-adrenergic mechanisms'. Together they form a unique fingerprint.

  • Cite this